BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arii S, Teramoto K, Kawamura T, Okamoto H, Kaido T, Mori A, Imamura M. Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience. J Hepatobiliary Pancreat Surg. 2001;8:397-403. [PMID: 11702247 DOI: 10.1007/s005340100000] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Iwaki K, Ohta M, Ishio T, Kai S, Iwashita Y, Shibata K, Himeno K, Seike M, Fujioka T, Kitano S. Metastasis of hepatocellular carcinoma to spleen and small intestine. J Hepatobiliary Pancreat Surg 2008;15:213-9. [PMID: 18392718 DOI: 10.1007/s00534-007-1230-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
2 Hendriquez R, Keihanian T, Goyal J, Abraham RR, Mishra R, Girotra M. Radiofrequency ablation in the management of primary hepatic and biliary tumors. World J Gastrointest Oncol 2022; 14(1): 203-215 [DOI: 10.4251/wjgo.v14.i1.203] [Reference Citation Analysis]
3 Weber S, Jarnagin W, Duffy A, O'reilly EM, Abou-alfa GK, Blumgart L. Liver and Bile Duct Cancer. Abeloff's Clinical Oncology. Elsevier; 2008. pp. 1569-94. [DOI: 10.1016/b978-0-443-06694-8.50088-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Chen L, Guo P, He Y, Chen Z, Chen L, Luo Y, Qi L, Liu Y, Wu Q, Cui Y, Fang F, Zhang X, Song T, Guo H. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway. Cell Death Dis. 2018;9:513. [PMID: 29725020 DOI: 10.1038/s41419-018-0534-9] [Cited by in Crossref: 71] [Cited by in F6Publishing: 82] [Article Influence: 17.8] [Reference Citation Analysis]
5 Tajima T, Yoshimitsu K, Irie H, Aibe H, Shinozaki K, Nishie A, Honda H, Shimada M. Detecting Postsurgical Recurrent Hepatocellular Carcinoma With Multiphasic Helical Computed Tomography: Intrahepatic Metastasis or Multicentric Occurrence? Journal of Computer Assisted Tomography 2005;29:42-50. [DOI: 10.1097/01.rct.0000146482.64324.6e] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
6 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(3): 249-254 [DOI: 10.11569/wcjd.v11.i3.249] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Wang B, Xia CY, Lau WY, Lu XY, Dong H, Yu WL, Jin GZ, Cong WM, Wu MC. Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: a new strategy for hepatic surgery. J Am Coll Surg. 2013;217:1054-1062. [PMID: 24246620 DOI: 10.1016/j.jamcollsurg.2013.07.402] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
8 Nuta J, Shingaki N, Ida Y, Shimizu R, Hayami S, Ueno M, Fukatsu K, Itonaga M, Yoshida T, Maeda Y, Moribata K, Deguchi H, Maekita T, Iguchi M, Kato J, Yamaue H, Tamai H. Irregular Defects in Hepatocellular Carcinomas During the Kupffer Phase of Contrast-Enhanced Ultrasonography with Perfluorobutane Microbubbles: Pathological Features and Metastatic Recurrence After Surgical Resection. Ultrasound Med Biol 2017;43:1829-36. [PMID: 28625558 DOI: 10.1016/j.ultrasmedbio.2017.04.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
9 Ali SA, Amin DH, Abdelkhalek YI. Efficiency of whole-body 18F-FDG PET CT in detecting the cause of rising serum AFP level in post-therapeutic follow-up for HCC patients. Jpn J Radiol 2020;38:472-9. [PMID: 32078123 DOI: 10.1007/s11604-020-00930-8] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Abou-alfa GK, Jarnagin W, El Dika I, D'angelica M, Lowery M, Brown K, Ludwig E, Kemeny N, Covey A, Crane CH, Harding J, Shia J, O'reilly EM. Liver and Bile Duct Cancer. Abeloff's Clinical Oncology. Elsevier; 2020. pp. 1314-1341.e11. [DOI: 10.1016/b978-0-323-47674-4.00077-3] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Beppu T, Imai K, Okuda K, Eguchi S, Kitahara K, Taniai N, Ueno S, Shirabe K, Ohta M, Kondo K. Anterior approach for right hepatectomy with hanging maneuver for hepatocellular carcinoma: a multi-institutional propensity score-matching study. J Hepatobiliary Pancreat Sci. 2017;24:127-136. [PMID: 28181419 DOI: 10.1002/jhbp.431] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
12 Gish RG. Hepatocellular carcinoma: overcoming challenges in disease management. Clin Gastroenterol Hepatol. 2006;4:252-261. [PMID: 16527686 DOI: 10.1016/j.cgh.2006.01.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
13 Mashiko T, Masuoka Y, Nakano A, Tsuruya K, Hirose S, Hirabayashi K, Kagawa T, Nakagohri T. Intussusception due to hematogenous metastasis of hepatocellular carcinoma to the small intestine: A case report. World J Gastroenterol 2020; 26(42): 6698-6705 [PMID: 33268957 DOI: 10.3748/wjg.v26.i42.6698] [Reference Citation Analysis]
14 Maki A, Matsuda M, Asakawa M, Kono H, Fujii H, Matsumoto Y. Decreased expression of CD28 coincides with the down-modulation of CD3zeta and augmentation of caspase-3 activity in T cells from hepatocellular carcinoma-bearing patients and hepatitis C virus-infected patients. J Gastroenterol Hepatol 2004;19:1348-56. [DOI: 10.1111/j.1440-1746.2004.03455.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
15 Kishi Y, Nara S, Esaki M, Hiraoka N, Shimada K. Salvage hepatectomy for local recurrence of hepatocellular carcinomas offers survival comparable to that of matched patients who undergo primary hepatectomies. Eur J Surg Oncol 2017;43:1076-82. [PMID: 28456443 DOI: 10.1016/j.ejso.2017.03.021] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Choi D, Lim HK, Rhim H, Kim Y, Yoo BC, Paik SW, Joh J, Park CK. Percutaneous Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma After Hepatectomy: Long-term Results and Prognostic Factors. Ann Surg Oncol 2007;14:2319-29. [DOI: 10.1245/s10434-006-9220-8] [Cited by in Crossref: 95] [Cited by in F6Publishing: 94] [Article Influence: 6.3] [Reference Citation Analysis]
17 Choi D, Lim HK, Kim MJ, Lee SH, Kim SH, Lee WJ, Lim JH, Joh JW, Kim YI. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology. 2004;230:135-141. [PMID: 14631050 DOI: 10.1148/radiol.2301021182] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 3.7] [Reference Citation Analysis]
18 Sala M, Fuster J, Llovet JM, Navasa M, Solé M, Varela M, Pons F, Rimola A, García-Valdecasas JC, Brú C. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation. Liver Transpl. 2004;10:1294-1300. [PMID: 15376311 DOI: 10.1002/lt.20202] [Cited by in Crossref: 223] [Cited by in F6Publishing: 202] [Article Influence: 13.1] [Reference Citation Analysis]
19 Abou-alfa GK, Jarnagin W, Lowery M, D'angelica M, Brown K, Ludwig E, Covey A, Kemeny N, Goodman KA, Shia J, O'reilly EM. Liver and Bile Duct Cancer. Abeloff's Clinical Oncology. Elsevier; 2014. pp. 1373-1396.e8. [DOI: 10.1016/b978-1-4557-2865-7.00080-1] [Reference Citation Analysis]
20 Choi G, Kim D, Kang C, Kim K, Choi J, Lee W, Kim B. Prognostic Factors and Optimal Treatment Strategy for Intrahepatic Nodular Recurrence After Curative Resection of Hepatocellular Carcinoma. Ann Surg Oncol 2008;15:618-29. [DOI: 10.1245/s10434-007-9671-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 3.5] [Reference Citation Analysis]
21 Kishi Y, Shimada K, Nara S, Esaki M, Kosuge T. Role of hepatectomy for recurrent or initially unresectable hepatocellular carcinoma. World J Hepatol 2014; 6(12): 836-843 [PMID: 25544870 DOI: 10.4254/wjh.v6.i12.836] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
22 Yang W, Chen MH, Yin SS, Yan K, Gao W, Wang YB, Huo L, Zhang XP, Xing BC. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence. AJR Am J Roentgenol. 2006;186:S275-S283. [PMID: 16632688 DOI: 10.2214/ajr.04.1573] [Cited by in Crossref: 47] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
23 Shimizu R, Tamai H, Mori Y, Shingaki N, Maeshima S, Nuta J, Maeda Y, Moribata K, Muraki Y, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M. The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma. Hepatol Int 2016;10:328-39. [DOI: 10.1007/s12072-015-9678-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
24 Emond JC, Samstein B, Renz JF. A critical evaluation of hepatic resection in cirrhosis: optimizing patient selection and outcomes. World J Surg. 2005;29:124-130. [PMID: 15654659 DOI: 10.1007/s00268-004-7633-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
25 Shirai K, Tamai H, Shingaki N, Mori Y, Moribata K, Enomoto S, Deguchi H, Ueda K, Maekita T, Inoue I, Iguchi M, Yanaoka K, Oka M, Ichinose M. Clinical features and risk factors of extrahepatic seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma: Seeding after RFA for HCC. Hepatology Research 2011;41:738-45. [DOI: 10.1111/j.1872-034x.2011.00841.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
26 Zhang X, Liu S, Shen C, Wu Y, Zhang L, Chen X, Lu F. DNA methylation consistency implicates the primary tumor cell origin of recurrent hepatocellular carcinoma. Epigenomics 2015;7:581-92. [PMID: 25815780 DOI: 10.2217/epi.15.23] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
27 Lin CY, Chen JH, Liang JA, Lin CC, Jeng LB, Kao CH. 18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: a systematic review and meta-analysis. Eur J Radiol 2012;81:2417-22. [PMID: 21899970 DOI: 10.1016/j.ejrad.2011.08.004] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
28 Wang K, Liu G, Li J, Yan Z, Xia Y, Wan X, Ji Y, Lau WY, Wu M, Shen F. Early intrahepatic recurrence of hepatocellular carcinoma after hepatectomy treated with re-hepatectomy, ablation or chemoembolization: a prospective cohort study. Eur J Surg Oncol 2015;41:236-42. [PMID: 25434327 DOI: 10.1016/j.ejso.2014.11.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
29 Hung BP, Shih KC. Surgery, ablation or combination. J Formos Med Assoc 2008;107:971; author reply 972. [PMID: 19129060 DOI: 10.1016/S0929-6646(09)60023-1] [Reference Citation Analysis]
30 Schindera ST, Nelson RC, DeLong DM, Clary B. Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablation. J Vasc Interv Radiol. 2006;17:1631-1637. [PMID: 17057005 DOI: 10.1097/01.rvi.0000239106.98853.b8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
31 Matsumoto M, Yanaga K, Shiba H, Wakiyama S, Sakamoto T, Futagawa Y, Gocho T, Ishida Y, Ikegami T. Treatment of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Ann Gastroenterol Surg 2021;5:538-52. [PMID: 34337303 DOI: 10.1002/ags3.12449] [Reference Citation Analysis]
32 Nuta J, Tamai H, Mori Y, Shingaki N, Maeshima S, Shimizu R, Maeda Y, Moribata K, Niwa T, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M. Kupffer Imaging by Contrast-Enhanced Sonography With Perfluorobutane Microbubbles Is Associated With Outcomes After Radiofrequency Ablation of Hepatocellular Carcinoma. Journal of Ultrasound in Medicine 2016;35:359-71. [DOI: 10.7863/ultra.15.04067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
33 Yang PC, Ho CM, Hu RH, Ho MC, Wu YM, Lee PH. Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma. World J Hepatol 2016; 8(31): 1309-1317 [PMID: 27872682 DOI: 10.4254/wjh.v8.i31.1309] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
34 Feng K, Ma KS. Value of radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Gastroenterol 2014; 20(20): 5987-5998 [PMID: 24876721 DOI: 10.3748/wjg.v20.i20.5987] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
35 McWilliams JP, Yamamoto S, Raman SS, Loh CT, Lee EW, Liu DM, Kee ST. Percutaneous ablation of hepatocellular carcinoma: current status. J Vasc Interv Radiol. 2010;21:S204-S213. [PMID: 20656230 DOI: 10.1016/j.jvir.2009.11.025] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
36 Ali MA, Li WF, Wang JH, Lin CC, Chen YJ, Lin TL, Lin TS, Lu SN, Wang CC, Chen CL. Impact of pathological features of primary hepatocellular carcinoma on the outcomes of intrahepatic recurrence management: single center experience from Southern Taiwan. HPB (Oxford) 2016;18:851-60. [PMID: 27567971 DOI: 10.1016/j.hpb.2016.07.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
37 Young K, Fidelman N, Yao FY, Hills NK, Kohi MP, Kolli KP, Taylor AG, Kerlan RK Jr. Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma. Liver Transpl 2015;21:454-67. [PMID: 25678220 DOI: 10.1002/lt.24090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
38 Choi D, Lim HK, Rhim H. Concurrent and subsequent radiofrequency ablation combined with hepatectomy for hepatocellular carcinomas. World J Gastrointest Surg 2010; 2(4): 137-142 [PMID: 21160862 DOI: 10.4240/wjgs.v2.i4.137] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
39 Kishi Y, Saiura A, Yamamoto J, Koga R, Seki M, Morimura R, Yoshioka R, Kokudo N, Yamaguchi T. Repeat treatment for recurrent hepatocellular carcinoma: is it validated? Langenbecks Arch Surg. 2011;396:1093-1100. [PMID: 21847622 DOI: 10.1007/s00423-011-0837-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
40 Livraghi T, Meloni F, Morabito A, Vettori C. Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center. Liver Transpl. 2004;10:S98-106. [PMID: 14762848 DOI: 10.1002/lt.20053] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 4.0] [Reference Citation Analysis]
41 Kishi Y, Hasegawa K, Sugawara Y, Kokudo N. Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection. Int J Hepatol. 2011;2011:728103. [PMID: 21994868 DOI: 10.4061/2011/728103] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
42 Satiya J, Schwartz I, Tabibian JH, Kumar V, Girotra M. Ablative therapies for hepatic and biliary tumors: endohepatology coming of age. Transl Gastroenterol Hepatol 2020;5:15. [PMID: 32258519 DOI: 10.21037/tgh.2019.10.17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
43 Lee HS, Choi GH, Joo DJ, Kim MS, Choi JS, Kim SI. The clinical behavior of transplantable recurrent hepatocellular carcinoma after curative resection: implications for salvage liver transplantation. Ann Surg Oncol 2014;21:2717-24. [PMID: 24916744 DOI: 10.1245/s10434-014-3597-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
44 Shin DS, Ingraham CR, Dighe MK, Wang C, Vaidya S, Moshiri M, Lall C, Park JO, Bhargava P. Surgical resection of a malignant liver lesion: what the surgeon wants the radiologist to know. AJR Am J Roentgenol 2014;203:W21-33. [PMID: 24951226 DOI: 10.2214/AJR.13.11701] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]